Beyond autonomic neuromodulation: Acetylcholinesterase inhibitor against peripheral artery disease Chang-Ning Hao, Yi-Qin Shi, Ze-En Cheng, Xianwu Cheng International Journal of Cardiology Volume 178, Pages 253-255 (January 2015) DOI: 10.1016/j.ijcard.2014.10.048 Copyright © 2014 Elsevier Ireland Ltd Terms and Conditions
Fig. 1 Acetylcholinesterase inhibitor influences multiple cell components involved in peripheral artery disease that contribute to angiomyogenesis. Abbreviations: nAChRs: nicotinic acetylcholine receptors; AChEI: acetylcholinesterase inhibitor; ECs: endothelial cells; EPCs: endothelial progenitor cells; FGF: fibroblast growth factor; HIF-1α: hypoxia-inducible factor-1 alpha; IL-1β: interleukin-1 beta; Mos: monocytes; Mφs: macrophages; VEGF: vascular endothelial growth factor. International Journal of Cardiology 2015 178, 253-255DOI: (10.1016/j.ijcard.2014.10.048) Copyright © 2014 Elsevier Ireland Ltd Terms and Conditions